Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising
source: pixabay.com

Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising

According to a story from BioSpace, the biopharmaceutical company Bioniz Therapeutics, Inc., has recently announced the release of interim results from its phase 1/2 clinical trial. This trial is investigating…

Continue Reading Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising
This Phase 3 Cutaneous T-Cell Lymphoma Trial Has Completed Enrollment
source: pixabay.com

This Phase 3 Cutaneous T-Cell Lymphoma Trial Has Completed Enrollment

According to a story from PR Newswire, the biopharmaceutical company Soligenix, Inc. has announced recently that its phase 3 clinical trial has officially completed enrollment. This trial is testing the…

Continue Reading This Phase 3 Cutaneous T-Cell Lymphoma Trial Has Completed Enrollment
Company Releases Early Clinical Data For Experimental Blood Cancer Drug
SarahMarciano / Pixabay

Company Releases Early Clinical Data For Experimental Blood Cancer Drug

According to a story from pm360online.com, the biopharmaceutical company miRagen Therapeutics, Inc., recently presented Phase I clinical trial data regarding the company's experimental drug cobomarsen. This data was presented at…

Continue Reading Company Releases Early Clinical Data For Experimental Blood Cancer Drug
Researchers Have Made an Important Microbiology Discovery Related to Cancer
Source: Pixabay

Researchers Have Made an Important Microbiology Discovery Related to Cancer

Scientists at the University of Georgia have identified a rare type of glycosylation (more on what that is in a second) which plays a major role in the function of…

Continue Reading Researchers Have Made an Important Microbiology Discovery Related to Cancer
A New Drug May Be Coming to the Market for Cutaneous T-cell Lymphoma
https://pixabay.com/en/youth-active-jump-happy-sunrise-570881/

A New Drug May Be Coming to the Market for Cutaneous T-cell Lymphoma

A phase 3 clinical trial has produced positive results for cutaneous T-cell lymphoma (CTCL) patients. The drug tested is called brentuximab vedotin (Adcetris). Specifically, the drug was created to treat…

Continue Reading A New Drug May Be Coming to the Market for Cutaneous T-cell Lymphoma
Close Menu